These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 25727921)

  • 1. Namibia's transition from whole blood-derived pooled platelets to single-donor apheresis platelet collections.
    Pitman JP; Basavaraju SV; Shiraishi RW; Wilkinson R; von Finckenstein B; Lowrance DW; Marfin AA; Postma M; Mataranyika M; Smit Sibinga CT
    Transfusion; 2015 Jul; 55(7):1685-92. PubMed ID: 25727921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data.
    Daurat A; Roger C; Gris J; Daurat G; Feissel M; Le Manach Y; Lefrant J; Muller L
    Transfusion; 2016 Jun; 56(6):1295-303. PubMed ID: 26814984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions.
    Eder AF; Dy BA; DeMerse B; Wagner SJ; Stramer SL; O'Neill EM; Herron RM
    Transfusion; 2017 Dec; 57(12):2969-2976. PubMed ID: 28880363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R; Smith J; Vesely SK; Dale GL; Holter J
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
    Katz L; Palmer K; McDonnell E; Kabat A
    Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).
    Eder AF; Kennedy JM; Dy BA; Notari EP; Weiss JW; Fang CT; Wagner S; Dodd RY; Benjamin RJ;
    Transfusion; 2007 Jul; 47(7):1134-42. PubMed ID: 17581147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
    Fontana S; Mordasini L; Keller P; Taleghani BM
    Transfusion; 2006 Nov; 46(11):2004-10. PubMed ID: 17076857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood cell telomere length measurements indicate that hematopoietic stem cell turnover is not significantly increased in whole blood and apheresis PLT donors.
    Scheding S; Ersöz I; Hartmann U; Bartolvic K; Balabanov S; Salama A; Kanz L; Brümmendorf TH
    Transfusion; 2003 Aug; 43(8):1089-95. PubMed ID: 12869115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographics of apheresis platelet donors in five blood centers in China.
    Guo N; Wang J; Ness P; Yao F; Dong X; Bi X; Mei H; Li J; He W; Lu Y; Ma H; Wen X; Huang M; Liu J; Wright DJ; Shan H;
    Transfusion; 2012 Mar; 52(3):560-6. PubMed ID: 21895674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure.
    Rios JA; Schlumpf KS; Kakaiya RM; Triulzi DJ; Roback JD; Kleinman SH; Murphy EL; Gottschall JL; Carey PM;
    Transfusion; 2011 Jun; 51(6):1197-206. PubMed ID: 21182532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of plateletpheresis by donors with low-normal platelet counts.
    Rogers RL; Johnson H; Ludwig G; Winegarden D; Randels MJ; Strauss RG
    J Clin Apher; 1995; 10(4):194-7. PubMed ID: 8770712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
    Méndez A; Wägli F; Schmid I; Frey BM
    Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality.
    Garner SF; Jones CI; Stephens J; Burns P; Walton J; Bernard A; Angenent W; Ouwehand WH; Goodall AH;
    Transfusion; 2008 Apr; 48(4):673-80. PubMed ID: 18194381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro storage properties of Amicus apheresis platelets collected using single- and double-needle procedures from the same donors.
    Wagner SJ; Seetharaman S; Kurtz J
    Transfusion; 2012 Mar; 52(3):524-8. PubMed ID: 21880047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
    Thiele T; Alt-Mayer T; Greinacher A; Bux J
    Vox Sang; 2016 Nov; 111(4):350-356. PubMed ID: 27432635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.
    Fontana S; Rados L; Schmid P; Leibundgut EO; Taleghani BM
    Transfusion; 2011 Sep; 51(9):2034-43. PubMed ID: 21438883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006.
    Eder AF; Dy BA; Kennedy JM; Notari Iv EP; Strupp A; Wissel ME; Reddy R; Gibble J; Haimowitz MD; Newman BH; Chambers LA; Hillyer CD; Benjamin RJ
    Transfusion; 2008 Sep; 48(9):1809-19. PubMed ID: 18631167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.